Leading those efforts was Shigetaka Komori, who stepped aside last month after 20 years to become an executive adviser to Fujifilm. He focused the 87-year-old company on leveraging its film making technology, boosted by strategic acquisitions, to become a leader in biopharmaceuticals. It’s something Japanese companies should stick to: doing what they’re good at, such as fine-tuned manufacturing and materials. Japanese companies still tend to set long-term horizons. “While problems remain, I am firm in my belief that Japanese companies have great potential.

Source: ABC News July 13, 2021 03:45 UTC